Versant Ventures is a San Francisco-based venture capital firm founded in 1999 that specializes in healthcare and biotechnology investments. The firm invests across all stages, from seed to growth, with a focus on companies developing novel therapeutics, medical devices, and life sciences innovations. It operates globally with offices across the United States, Canada, and Europe, and manages multi-billion-dollar assets. Versant combines traditional venture investing with a company creation model, including in-house scientific teams that help launch new biotech ventures. Its strategy centers on translating scientific discoveries into scalable healthcare businesses.